UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008154
Receipt number R000009574
Scientific Title Multicenter study of the effect of Elemental diet for Perioperative nutrition in Laparoscopic colorectal Surgery.
Date of disclosure of the study information 2012/06/13
Last modified on 2013/12/20 16:26:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter study of the effect of Elemental diet for Perioperative nutrition in Laparoscopic colorectal Surgery.

Acronym

EPLAS

Scientific Title

Multicenter study of the effect of Elemental diet for Perioperative nutrition in Laparoscopic colorectal Surgery.

Scientific Title:Acronym

EPLAS

Region

Japan


Condition

Condition

Colorectal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

In laparoscopic colorectal surgery, by shortening the length of fasting in perioperative period as much as possible, and performing nutrition management using an elemental diet(Elental), the effect on postoperative recovery, surgical technique, and safety is examined using a clinical parameter, inspection data, a questionnaire, etc.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The ratio of patients which fulfilled all the items of the criteria for discharge less than postoperative 7 day.

Key secondary outcomes

1) Dietary intake
2) Rising time
3) QOL
4) Safety
5) Compliance of elemental diet


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Elemental diet group:
900mL intake of Elental is performed on the day before surgery. 300mL intake is performed by two and a half hour before the operation as far as possible.
300mL of Elental is taken when the seated position is possible after five hours of operation.
900 mL/day intake of Elental is performed one or two days after surgery as far as possible.
Three days after surgery, dietary intake (rice porridge in half degree) is started and Elental is taken in 300-900 mL/day.
Four days after surgery, rice porridge in full degree is started and medication of Elental is discontinued.

Interventions/Control_2

Control group:
Fasting is performed on the day before surgery and the operation day.
Intake of fluid is only allowed for two days after surgery. Rice porridge in half degree is started three days after a surgery. Rice porridge in full degree is started four days after a surgery.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

76 years-old >

Gender

Male and Female

Key inclusion criteria

1) Colorectal cancer characterized by tumor found in the colon and the rectum RS section.
2) A laparoscopic surgery is planned.
3)Patients with histologically proven colorectal cancer.
4) The case diagnosed as having a curative operation
5) Sufficient function of main organ.
6) The age of patients is less than 76 years old when informed consent is obtained.
7) ECOG Performance Status (PS) of 0 or 1.
8) Voluntarily gave the written informed consent.

Key exclusion criteria

1) Ileus, anemia by neoplasm bleeding, and tumor perforation.
2) Patients with the history of chemotherapy, radiotherapy, immunotherapy.
3) Patients with severe complications.
1.uncontrolled diabetes.
2.uncontrolled hypertension.
3.Interstitial pneumonias, pulmonary fibrosis, severe emphysema.
4) Patients at risk for aspiration (Parkinson's Disease, nerve/ myopathy, etc.).
5) Patients have psychosis or psychiatric symptoms and are judged as inappropriate for this study.
6) Judged as inappropriate for this study by the investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshiaki Shichinohe

Organization

Hokkaido University Hospital

Division name

Gastroenterological Surgery II

Zip code


Address

West-7, North-15, Kita-ku, Sapporo

TEL

011-706-7714

Email

shichino@med.hokudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Toshiaki Shichinohe

Organization

Hokkaido University Hospital

Division name

Gastroenterological Surgery II

Zip code


Address

West-7, North-15, Kita-ku, Sapporo

TEL

011-706-7714

Homepage URL


Email

shichino@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital
Gastroenterological Surgery II

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tonan Hospital, Obihiro-Kosei General Hospital, Hokkaido Gastroenterology Hospital, Sapporo Medical Center NTT EC, Teine Keijinkai Hospital, Steel Memorial Muroran Hospital, and others.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)


Other administrative information

Date of disclosure of the study information

2012 Year 06 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 03 Month 20 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 01 Day

Last follow-up date

2013 Year 09 Month 30 Day

Date of closure to data entry

2014 Year 01 Month 30 Day

Date trial data considered complete

2014 Year 02 Month 10 Day

Date analysis concluded

2014 Year 02 Month 28 Day


Other

Other related information



Management information

Registered date

2012 Year 06 Month 13 Day

Last modified on

2013 Year 12 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009574


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name